Management of Benign Prostatic Hyperplasia by Transurethral Laser Ablation in Patients Treated with Warfarin Anticoagulation
- 1 January 1994
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 151 (1), 79-81
- https://doi.org/10.1016/s0022-5347(17)34876-0
Abstract
Transurethral laser ablation of the prostate gland was used to treat benign prostatic hyperplasia in 10 patients on warfarin anticoagulant therapy who had either significant clinical symptoms or who were in urinary retention. Anticoagulant therapy did not require alteration at any stage during treatment. All patients noticed improvements in symptom score assessments, flow rates and residual urine volumes following this procedure, and no significant complications were encountered. The hemostatic nature of neodymium:YAG laser energy as applied in this procedure appears to result in a technical improvement upon conventional transurethral resection for the treatment of symptomatic benign prostatic hyperplasia in patients taking warfarin anticoagulant therapy.Keywords
This publication has 8 references indexed in Scilit:
- The American Urological Association Symptom Index for Benign Prostatic HyperplasiaJournal of Urology, 1992
- Medical treatment for benign prostatic hyperplasia.BMJ, 1992
- Pathologic changes occurring in the prostate following transurethral laser prostatectomyLasers in Surgery and Medicine, 1992
- Preoperative use of 5-fluorouracil to reduce operative bleeding in transurethral resection of prostateUrology, 1989
- Preoperative Prediction of Results of Prostatectomy by a Symptom Score and Radionuclide UroflowmetryEuropean Urology, 1988
- Transurethral Incision of Prostate Compared with Transurethral Resection of Prostate in 132 Matching CasesJournal of Urology, 1987
- Electroresection of the Prostate in Patients Treated with HeparinJournal of Urology, 1980
- Transurethral Prostatic Resection in Patients with Prosthetic Cardiac ValvesJournal of Urology, 1975